InvestorsHub Logo
Followers 3
Posts 65
Boards Moderated 0
Alias Born 10/30/2013

Re: None

Thursday, 12/19/2013 5:08:02 AM

Thursday, December 19, 2013 5:08:02 AM

Post# of 5879
This is GOOD NEWS is it not?? DEC 11 news excerpt, John Yu, MD, Founder, Chairman and Chief Scientific Officer of ImmunoCellular Therapeutics, said, “We are quite pleased to see such a strongly statistically significant result in PFS in this exploratory trial, and believe that in conjunction with the indications of a survival benefit, these results provide a strong medical rationale for continued development of ICT-107 as a potential treatment for glioblastoma. IMO, IMUC will recover substantial PPS.